Vaginal dilator use more than 9 months is a main prognostic factor for reducing G2‑late vaginal complications in 3D‑vaginal‑cuff brachytherapy (interventional radiotherapy)?
Abstract:Purpose
Analyse the impact of different prognostic factors on G2-late vaginal complications after vaginal brachytherapy (VBT) ± external beam radiotherapy (EBRT) in postoperative endometrial cancer (PEC).
Methods
One hundred and twenty-six PEC patients treated with VBT ± EBRT were retrospectively analysed considering age, body mass index, applicator diameter, clinical target volume (CTV), use of dilators, chemotherapy and EQD2(α/β=3) at the most exposed 2 … Show more
“…The sexuality of the patients undergoing different radiotherapy treatment modalities has not been well studied and needs further analysis. The use of vaginal dilators in these patients seems to reduce vaginal complications but is probably not the only aspect that should be taken into account after treatments [25,26].…”
This special issue of “Cancers” explores unusual and very particular aspects of interventional radiotherapy (brachytherapy) in gynecological cancer [...]
“…The sexuality of the patients undergoing different radiotherapy treatment modalities has not been well studied and needs further analysis. The use of vaginal dilators in these patients seems to reduce vaginal complications but is probably not the only aspect that should be taken into account after treatments [25,26].…”
This special issue of “Cancers” explores unusual and very particular aspects of interventional radiotherapy (brachytherapy) in gynecological cancer [...]
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.